Macomics
2 known investors
Macomics is a drug discovery company developing therapies that target macrophage activity for diseases with limited or ineffective treatment options. It operates in the biotechnology and therapeutics sector.
Investors · 2
Companies House · registry record
View on Companies House ↗- Registered name
- MACOMICS LTD
- Company number
- SC612928
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 6 Nov 2018
- Registered office
- 137a George Street, Edinburgh, EH2 4JY
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Mar 2025 · next due 31 Dec 2026
- Confirmation statement
- last made up to 5 Nov 2025 · next due 19 Nov 2026
Current officers · 6
- Thorntons Law Llp — corporate secretary, appointed 25 Feb 2020
- Luca Cassetta — director, appointed 20 Jun 2023
- Jane Elizabeth Dancer — director, appointed 23 Jun 2020
- Kevin Lee — director, appointed 1 Jul 2023
- Stephen Samuel Myatt — director, appointed 1 Mar 2021
- Elizabeth Ann Roper — director, appointed 26 Feb 2020
Source: Companies House public register · retrieved 23 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Macomics do?
- Macomics is a drug discovery company developing therapies that target macrophage activity for diseases with limited or ineffective treatment options. It operates in the biotechnology and therapeutics sector.
- Who are Macomics's investors?
- Macomics's investors include Epidarex Capital, Scottish Enterprise.